Procedure · Curing defects
How to ratify defective corporate actions
Diligence finds gaps. Resolutions are missing, notice was short, a 409A was stale at a grant date, an articles amendment was approved but never filed. Ratification is the statutory or common-law mechanism for curing these defects: a subsequent resolution, a public filing, sometimes a court order, that confirms the prior action and forecloses challenge. The procedure below documents how to run that curative path.
Quick facts
Ratification of defective corporate acts
| When | On discovery of a defective past action, usually in diligence or pre-financing review |
|---|---|
| Authorized by | The board, and shareholders where the original action would have required shareholder approval |
| Statutory anchor | DGCL §§ 204 and 205; Companies Act 2006 s. 239 (limited); common-law in CBCA/OBCA |
| Effective on | The original action date, subject to third-party rights acquired in reliance on the defect |
At a glance
- Most procedural defects can be ratified by subsequent board (and shareholder, where applicable) action
- The ratifying resolution must describe the defect specifically, not generically
- Statutory ratification under DGCL § 204 provides express procedure and a § 205 court validation option
- Substantive defects (capital impairment, solvency-test violations) cannot be cured by ratification alone
- Ratification is between the corporation and its constituents; third-party reliance rights survive
On this page
Steps
Identify the defective corporate action and the nature of the defect
A defective corporate action is one that was taken but failed to comply with the corporation statute, the articles, the bylaws, or another required procedure. Common defects: a share issuance authorized by a board that lacked quorum; an option grant made without a current 409A; an articles amendment never filed with the registrar; a director election with inadequate notice; a contract signed by an officer outside their authority. Catalogue each defective action, the nature of the defect, the date, and the participants.Determine the ratification path: statutory or common-law
Some jurisdictions provide a statutory ratification procedure: DGCL §§ 204 and 205 permit ratification of defective corporate acts by board resolution (and shareholder approval if the underlying action would have required it), with the option of a Court of Chancery order under § 205 to validate the action against challenge. Other jurisdictions rely on common-law ratification: a subsequent board or shareholder resolution validating the past action, effective from the original date. CBCA and OBCA take the common-law approach; UK Companies Act 2006 s. 239 codifies director-conflict ratification but otherwise relies on common law.Draft the ratifying resolution
The ratifying resolution describes the defective action in detail (what was done, when, by whom, and the defect), confirms that the action would have been properly authorized had the procedure been followed, and ratifies the action as of the original date. For statutory ratification under DGCL § 204, the resolution must include specific recitals (description of the act, date, defect, nature of failure of authorization) and follow the prescribed form. For common-law ratification, the resolution is in the same form as an original authorizing resolution, with the substantive added recital that the prior action is approved and ratified.Obtain board and (where required) shareholder approval
The board adopts the ratifying resolution. Where the defective action would have required shareholder approval (an articles amendment, a fundamental change, a class-affecting action), the shareholders must also approve the ratification at the threshold that would have been required for the original action. Notice of the ratification meeting describes the defective action and the ratification proposal so shareholders can evaluate. See how to pass a board resolution and how to call a special meeting.Make any required public filings
If the defective action required a public filing that was never made (an articles amendment, a change of registered office, a director-change notice), the filing is made now, with the effective date typically being the date of ratification (or the original date if the statute permits retroactive effect). DGCL § 204 permits a certificate of validation to be filed with the Secretary of State to publicly confirm the ratification. Other filings (notices of director changes, articles amendments) are made through the registrar's usual channel.Update the minute book and the affected records
The ratifying resolution, the supporting notice and proxy materials, the shareholder voting record (if applicable), and the public filing acknowledgments are retained in the minute book under the date of ratification. The records affected by the defective action (the share register entry for a defective issuance, the option ledger for a defective grant, the cap table) are reviewed and updated to reflect the ratified status. The original defect is not erased; the ratification stands alongside the defective action as the curative entry. See how to maintain a minute book.Consider court validation for high-risk defects
For defects that may attract challenge (a class-affecting share issuance, a fundamental change, an action involving a director's conflict), the corporation may seek a court order validating the ratification. Under DGCL § 205, the Court of Chancery has broad authority to validate defective corporate acts and the resulting securities, on application by the corporation or any interested person. Outside Delaware, comparable applications are available under general supervisory jurisdiction. A court order provides additional certainty against later collateral challenge.
Jurisdiction notes
Delaware provides the most developed ratification framework; other jurisdictions rely on common law or limited statutory provisions:
- Delaware (DGCL). Sections 204 and 205 codify ratification of defective corporate acts. Section 204 sets out the board and shareholder procedure for ratification, including the required content of the ratifying resolution and an optional certificate of validation. Section 205 gives the Court of Chancery broad authority to validate defective corporate acts, the resulting securities, and any consequential acts, on application by the corporation or any interested person. View jurisdiction guide
- California. No express ratification statute equivalent to DGCL § 204. Ratification proceeds on common-law principles: a subsequent board or shareholder resolution adopting the prior action. California Corporations Code § 211 governs board action and the common-law rules on ratification apply by analogy. Court applications under the corporation statute are available for specific relief. View jurisdiction guide
- Canada (CBCA). No express ratification statute. Ratification is by common-law principles: a subsequent properly authorized resolution validates the prior defective action, effective from the original date. CBCA s. 247 (court applications for compliance and rectification) provides a residual judicial remedy for defects that cannot be cured by ratification alone. View jurisdiction guide
- Ontario (OBCA). Same as CBCA: common-law ratification, with OBCA s. 248 (compliance orders) and s. 246 (oppression remedy) available for residual issues. View jurisdiction guide
- United Kingdom. Companies Act 2006 s. 239 expressly governs ratification of conduct by a director (the conduct must be ratified by ordinary resolution, with the director's own shares not counted). Outside director-conduct ratification, the UK relies on common-law ratification (a subsequent properly authorized resolution). Section 996 of the Act permits unfair-prejudice petitions for residual relief. View jurisdiction guide
Common mistakes
- Generic "we ratify all prior actions" resolution. A pre-financing cleanup resolution purports to ratify all defective actions taken in the prior years, without describing any specific defect. The resolution provides no real cure because it doesn't disclose what is being ratified. Diligence counsel rejects it as inadequate.
- Board ratification of action requiring shareholder approval. The defective action (an articles amendment, a fundamental change) required shareholder approval at the time. The corporation purports to ratify by board resolution only. The ratification does not cure the defect because the original procedure required shareholder approval, which still hasn't been obtained.
- Substantive defects assumed curable. A redemption that violated the solvency tests, or an issuance for less than the consideration required by the statute, cannot be ratified by subsequent resolution. The defect is in the substance of the action, not just the procedure of authorization. The remedy is unwinding or seeking court relief, not ratification.
- Public filing not made. The corporation ratifies an articles amendment by resolution but does not file the certificate of validation (Delaware) or the underlying articles of amendment (other jurisdictions). The registry continues to show the old articles; third parties relying on the registry are not bound by the ratified amendment.
- Third-party reliance ignored. The corporation ratifies a defective share issuance. A third party purchased the shares from the original issuer in reliance on a representation that they were validly issued. The third party's rights against the issuer (rescission, damages) survive the ratification because the ratification is between the corporation and its constituents.
In Octelligence
Defects surfaced, ratified, and recorded.
Octelligence's corporate-records health check identifies defects in resolutions, register entries, and statutory filings; the ratification workflow drafts the curative resolutions describing each defect specifically, runs the approvals, files the public records, and retains the ratification packet in the minute book. Diligence counsel sees the defect, the ratification, and the supporting filings in one chain.
See Digital Corporate RecordsFAQ
Common questions
A corporate action that was taken without complying with the formal authorization required by the corporation statute, the articles, the bylaws, or another mandatory procedure. Common examples: share issuances by a board that lacked quorum; option grants without 409A in place; articles amendments approved by shareholders but never filed; director elections with inadequate notice; transactions involving a conflicted director where conflicts disclosure procedures were not followed.
Most can, but some defects are not curable. Actions that violate the corporation statute substantively (not just procedurally) cannot be ratified by subsequent resolution. For example, a share issuance for less than the consideration required by the statute, a redemption that violated the solvency tests, or a distribution that impaired capital cannot be cured by ratification. The remedy for substantive defects is unwinding or seeking court-ordered relief, not ratification.
Ratification is the corporation's own act of approving a defective past action. Validation is a court order confirming that the action (and any consequential acts, like share issuances or contracts) are effective despite the defect. Validation is typically sought when the corporation has ratified but there is residual risk of challenge (for example, in advance of an acquisition where the acquirer's counsel wants additional comfort). Under DGCL § 205, the Court of Chancery has express authority to issue validation orders.
Generally from the original date, subject to the rights of third parties who relied on the defect. Statutory ratification under DGCL § 204 confirms the act is effective from the time of its purported approval. Common-law ratification typically also relates back to the original date. However, the rights of third parties (creditors, transferees, parties who could have challenged the original act) acquired in reliance on the defect before ratification are not extinguished. Ratification is between the corporation and its shareholders; it does not bind unrelated third parties without notice.
Yes, fully. The ratifying resolution must describe the defect specifically: what was done, when, who did it, what was wrong, and what the corrective effect of ratification is. Concealing the defect or describing it in vague terms undermines the ratification because it deprives shareholders (or directors) of the information needed to evaluate the ratification. Diligence counsel reviewing the minute book will read the ratifying resolution and any inadequate disclosure becomes itself a defect.
If shareholders or directors decline to ratify, the defective action remains defective and the corporation must address it differently: unwinding the action (cancellation, return of consideration), seeking court validation, settling with affected parties, or proceeding without ratification and accepting the risk of challenge. The choice depends on the materiality of the defect and the likelihood of challenge. For a non-material defect (a minor notice failure, a clerical error), proceeding without ratification may be acceptable; for a material defect (an unauthorized class issuance, a defective conflict transaction), court validation or unwinding is typically required.
Defects, cleanly cured
Ratification recorded with the defect it cures.
Specific defects identified, ratifying resolutions drafted, approvals obtained, filings made, and the curative chain retained in the minute book for diligence.